Silverarc Capital Management, LLC
Annual return '25
+16.6%
SPY '25
+17.7%
Alpha
-1.1ptsvs SPY
Invested
$979.8M
Holdings
67
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$KALV
KALVISTA PHARMACEUTICALS INC
Q1 2026: Exited (was 2.43M shares)
6.8%
02
$DNTH
DIANTHUS THERAPEUTICS INC
Q1 2026: Exited (was 750.1k shares)
6.5%
03
$COGT
COGENT BIOSCIENCES INC
Q1 2026: Exited (was 1.25M shares)
6.0%
04
$CELC
CELCUITY INC
Q1 2026: Exited (was 375.1k shares)
4.8%
05
$IMNM
IMMUNOME INC
Q1 2026: Exited (was 1.13M shares)
4.8%
06
$KOD
KODIAK SCIENCES INC
Q1 2026: Exited (was 1.02M shares)
4.5%
07
$NUVL
NUVALENT INC
Q1 2026: Exited (was 311.4k shares)
4.3%
08
$ABVX
ABIVAX SA
Q1 2026: Exited (was 422.2k shares)
4.0%
09
$GLUE
MONTE ROSA THERAPEUTICS INC
Q1 2026: Exited (was 1.03M shares)
3.9%
10
$ERAS
ERASCA INC
Q1 2026: Exited (was 1.32M shares)
3.5%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:41 UTC.